Prevention of preeclampsia

Abstract

Preeclampsia refers to a syndrome that is unique to human pregnancy. It is a complex and multisystem disorder associated with significant maternal and fetal morbidity and mortality. Efficiently predict or prevent the onset of preeclampsia is still not possible. Ideally, pregnant women at high risk of developing the disorder would be recognized in the first trimester of pregnancy, which would leave us enough time to effectively ensure adequate placentation and thus prevent or at least alleviate the development of the syndrome. The following review describes in details some of the today most commonly used preventive measures: low doses aspirin therapy, low weight molecular heparin therapy, calcium replacement therapy and n-3 (omega-3) replacement therapy.